Isofol Medical AB Financials
ISOFOL.XSTO
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | kr 0 | kr 0 | kr 0 | kr 1 | kr 13 | kr 22 |
| Total Operating Expenses | – | – | – | – | kr 180 | kr 227 |
| Operating Income | -kr 59 | -kr 56 | -kr 47 | -kr 42 | -kr 167 | -kr 204 |
| Non-Operating | ||||||
| Net Interest Expense | -kr 0 | -kr 0 | kr 0 | kr 0 | -kr 0 | -kr 0 |
| Other Non-Operating Income (Expense) | – | – | – | – | kr 8 | kr 4 |
| EBT (Earnings Before Tax) | – | – | – | – | -kr 160 | -kr 200 |
| Income Tax Expense | kr 0 | kr 0 | kr 0 | kr 0 | kr 0 | kr 0 |
| Earnings from Continuing Ops | – | – | – | – | -kr 160 | -kr 200 |
| Net Income | ||||||
| Net Income | -kr 57 | -kr 54 | -kr 43 | -kr 37 | -kr 160 | -kr 200 |
| Per Share Data | ||||||
| Revenue Per Share | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.08 | kr 0.18 |
| EPS (Basic) | -kr 0.20 | -kr 0.25 | -kr 0.24 | -kr 0.23 | -kr 0.99 | -kr 1.59 |
| EPS (Diluted) | -kr 0.20 | -kr 0.25 | -kr 0.24 | -kr 0.23 | -kr 0.99 | -kr 1.59 |
| Shares Outstanding | 320.5M | 217.2M | 183.8M | 161.5M | 161.4M | 125.9M |
Isofol Medical AB (ISOFOL.XSTO) financials: revenue, profit and margins
Isofol Medical AB (ISOFOL.XSTO) generated about SEK 0.00 in revenue and -SEK 57 million in net income over the trailing twelve months, growing at roughly -73.1% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is Isofol Medical AB's (ISOFOL.XSTO) revenue?+
Isofol Medical AB generated about SEK 0.00 in revenue over the trailing twelve months. Revenue has grown at roughly -73.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Isofol Medical AB profitable?+
Isofol Medical AB reported about -SEK 57 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
How fast is Isofol Medical AB growing?+
Isofol Medical AB's revenue has compounded at roughly -73.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ISOFOL.XSTO's margins and free cash flow. This is analysis from company filings, not investment advice.
Peers
Biotechnology · Pick stocks to compare with ISOFOL.XSTO
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ISOFOL.XSTO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.